Are you above the legal age to view this content in your province/state?

Home / Industry News / Thailand rolls out cannabis clinics based on traditional medicine

Thailand rolls out cannabis clinics based on traditional medicine

Thailand rolls out cannabis clinics based on traditional medicine

London, January 5, 2020 (INDEPENDENT)-Thailand has opened its first full-time cannabis clinics, which will offer traditional remedies based on the drug. 

The two new centres in Bangkok will also offer alternative cannabis-based medicine, which has been legal in the country since 2018.

Hundreds of people – including many cancer patients – received free oil at a new flagship clinic based at the Ministry of Public Health in a suburb of the capital. 

The initial cannabis-based medicine handed out will be used to treat migraines, insomnia, neck pain, muscle stiffness and nausea. 

Thailand, which has a tradition of using the drug to relieve pain and fatigue, plans to open 70 more cannabis clinics across the country, according to the public health minister. 

Anutin Charnvirakul said the clinic at his department is a “pilot” as Thailand “cannot produce enough doctors with expertise in cannabis”.

Around 25 cannabis clinics attached to hospitals already exist but are only open part-time due to a lack of specialised staff.

The southeast Asian country, previously known for its harsh anti-drug laws, legalised medical cannabis and research towards the end of 2018 in a drive to boost the country’s income from agriculture.

Read more

  • Travelling abroad for medical cannabis is exhausting and cruel
  • How cannabis could prevent a US-style opioid crisis in the UK
  • Thailand lawmakers vote to legalise medical marijuana

Cannabis production, cultivation and sale has been limited to licensed Thai producers for the next four years to protect the domestic industry.

Currently, only hospitals and research facilities are allowed to apply for cannabis production and extraction licenses, but the government is reviewing regulations to enable Thai businesses to apply for permits.

Independent news email

Only the best news in your inboxContinue

Register with your social account or click here to log inwould like to receive morning headlinesMonday – Friday plus breaking news alerts by email

The largest producer of medical cannabis is currently the health ministry’s Government Pharmaceutical Organisation.

Last November, the NHS was given the green light to use two medicines derived from the drug which are used to treat severe childhood epilepsy and complications from multiple sclerosis.   

It marked the first time any cannabis-based treatment had been approved for routine use by the NHS.

Disclaimer

Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.


Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.


DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.


Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.


Investment Value Finders is intended for those 21+ years of age only!

Check Also

BACK TO NEWS FSD PHARMA INC. ANNOUNCES C$10.125 MILLION PRIVATE PLACEMENT

BACK TO NEWS FSD PHARMA INC. ANNOUNCES C$10.125 MILLION PRIVATE PLACEMENT

TORONTO / June 4, 2020 / FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) …